128 related articles for article (PubMed ID: 12441364)
1. Modulation of estrogen receptor-dependent reporter construct activation and G0/G1-S-phase transition by polycyclic aromatic hydrocarbons in human breast carcinoma MCF-7 cells.
Vondrácek J; Kozubík A; Machala M
Toxicol Sci; 2002 Dec; 70(2):193-201. PubMed ID: 12441364
[TBL] [Abstract][Full Text] [Related]
2. Deregulation of cell proliferation by polycyclic aromatic hydrocarbons in human breast carcinoma MCF-7 cells reflects both genotoxic and nongenotoxic events.
Plísková M; Vondrácek J; Vojtesek B; Kozubík A; Machala M
Toxicol Sci; 2005 Feb; 83(2):246-56. PubMed ID: 15548639
[TBL] [Abstract][Full Text] [Related]
3. Aryl Hydrocarbon Receptor-Dependent Metabolism Plays a Significant Role in Estrogen-Like Effects of Polycyclic Aromatic Hydrocarbons on Cell Proliferation.
Hýžd'alová M; Pivnicka J; Zapletal O; Vázquez-Gómez G; Matthews J; Neca J; Pencíková K; Machala M; Vondrácek J
Toxicol Sci; 2018 Oct; 165(2):447-461. PubMed ID: 30137621
[TBL] [Abstract][Full Text] [Related]
4. Differential action of polycyclic aromatic hydrocarbons on endogenous estrogen-responsive genes and on a transfected estrogen-responsive reporter in MCF-7 cells.
Gozgit JM; Nestor KM; Fasco MJ; Pentecost BT; Arcaro KF
Toxicol Appl Pharmacol; 2004 Apr; 196(1):58-67. PubMed ID: 15050408
[TBL] [Abstract][Full Text] [Related]
5. Estrogenic activity of environmental polycyclic aromatic hydrocarbons in uterus of immature Wistar rats.
Kummer V; Masková J; Zralý Z; Neca J; Simecková P; Vondrácek J; Machala M
Toxicol Lett; 2008 Aug; 180(3):212-21. PubMed ID: 18634860
[TBL] [Abstract][Full Text] [Related]
6. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R
Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551
[TBL] [Abstract][Full Text] [Related]
7. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
Marsaud V; Gougelet A; Maillard S; Renoir JM
Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
[TBL] [Abstract][Full Text] [Related]
8. Differential action of chlorinated polycyclic aromatic hydrocarbons on aryl hydrocarbon receptor-mediated signaling in breast cancer cells.
Ohura T; Morita M; Kuruto-Niwa R; Amagai T; Sakakibara H; Shimoi K
Environ Toxicol; 2010 Apr; 25(2):180-7. PubMed ID: 19365803
[TBL] [Abstract][Full Text] [Related]
9. The aryl hydrocarbon receptor-dependent deregulation of cell cycle control induced by polycyclic aromatic hydrocarbons in rat liver epithelial cells.
Andrysík Z; Vondrácek J; Machala M; Krcmár P; Svihálková-Sindlerová L; Kranz A; Weiss C; Faust D; Kozubík A; Dietrich C
Mutat Res; 2007 Feb; 615(1-2):87-97. PubMed ID: 17141280
[TBL] [Abstract][Full Text] [Related]
10. Effects of estrogen on leptin gene promoter activation in MCF-7 breast cancer and JEG-3 choriocarcinoma cells: selective regulation via estrogen receptors alpha and beta.
O'Neil JS; Burow ME; Green AE; McLachlan JA; Henson MC
Mol Cell Endocrinol; 2001 May; 176(1-2):67-75. PubMed ID: 11369444
[TBL] [Abstract][Full Text] [Related]
11. Estradiol rapidly activates Akt via the ErbB2 signaling pathway.
Stoica GE; Franke TF; Wellstein A; Czubayko F; List HJ; Reiter R; Morgan E; Martin MB; Stoica A
Mol Endocrinol; 2003 May; 17(5):818-30. PubMed ID: 12554767
[TBL] [Abstract][Full Text] [Related]
12. Delayed activation of extracellular-signal-regulated kinase 1/2 is involved in genistein- and equol-induced cell proliferation and estrogen-receptor-alpha-mediated transcription in MCF-7 breast cancer cells.
Liu H; Du J; Hu C; Qi H; Wang X; Wang S; Liu Q; Li Z
J Nutr Biochem; 2010 May; 21(5):390-6. PubMed ID: 19427779
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
Bhat KP; Pezzuto JM
Cancer Res; 2001 Aug; 61(16):6137-44. PubMed ID: 11507064
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
15. In vitro profiling of toxic effects of environmental polycyclic aromatic hydrocarbons on nuclear receptor signaling, disruption of endogenous metabolism and induction of cellular stress.
Šimečková P; Pěnčíková K; Kováč O; Slavík J; Pařenicová M; Vondráček J; Machala M
Sci Total Environ; 2022 Apr; 815():151967. PubMed ID: 34843781
[TBL] [Abstract][Full Text] [Related]
16. Ligand-independent activation of estrogen receptor function by 3, 3'-diindolylmethane in human breast cancer cells.
Riby JE; Chang GH; Firestone GL; Bjeldanes LF
Biochem Pharmacol; 2000 Jul; 60(2):167-77. PubMed ID: 10825461
[TBL] [Abstract][Full Text] [Related]
17. Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences.
Iwanari M; Nakajima M; Kizu R; Hayakawa K; Yokoi T
Arch Toxicol; 2002 Jun; 76(5-6):287-98. PubMed ID: 12107646
[TBL] [Abstract][Full Text] [Related]
18. Activation of the estrogen-signaling pathway by p21(WAF1/CIP1) in estrogen receptor-negative breast cancer cells.
Chen X; Danes C; Lowe M; Herliczek TW; Keyomarsi K
J Natl Cancer Inst; 2000 Sep; 92(17):1403-13. PubMed ID: 10974076
[TBL] [Abstract][Full Text] [Related]
19. Interaction of PAH-related compounds with the alpha and beta isoforms of the estrogen receptor.
Fertuck KC; Kumar S; Sikka HC; Matthews JB; Zacharewski TR
Toxicol Lett; 2001 May; 121(3):167-77. PubMed ID: 11369471
[TBL] [Abstract][Full Text] [Related]
20. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
